| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myeloid Cells | 5 | 2015 | 57 | 1.820 |
Why?
|
| Dronabinol | 7 | 2014 | 84 | 1.420 |
Why?
|
| Cannabidiol | 2 | 2015 | 31 | 0.900 |
Why?
|
| Cannabinoids | 4 | 2018 | 90 | 0.820 |
Why?
|
| Food Hypersensitivity | 3 | 2013 | 20 | 0.810 |
Why?
|
| Hepatitis, Autoimmune | 3 | 2011 | 22 | 0.800 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2018 | 154 | 0.690 |
Why?
|
| Immune System | 1 | 2018 | 63 | 0.660 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2011 | 199 | 0.660 |
Why?
|
| Fetal Development | 1 | 2018 | 70 | 0.650 |
Why?
|
| Plant Proteins | 3 | 2013 | 48 | 0.650 |
Why?
|
| Manilkara | 2 | 2013 | 2 | 0.600 |
Why?
|
| Antigens, Plant | 2 | 2013 | 3 | 0.600 |
Why?
|
| T-Lymphocytes | 8 | 2022 | 595 | 0.590 |
Why?
|
| Immune Tolerance | 2 | 2013 | 114 | 0.550 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2015 | 234 | 0.550 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 2 | 2015 | 74 | 0.500 |
Why?
|
| PPAR gamma | 1 | 2015 | 95 | 0.500 |
Why?
|
| Hyaluronan Receptors | 2 | 2022 | 142 | 0.500 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2013 | 18 | 0.480 |
Why?
|
| Cannabis | 1 | 2015 | 115 | 0.460 |
Why?
|
| Receptor, Cannabinoid, CB1 | 5 | 2013 | 68 | 0.460 |
Why?
|
| Receptor, Cannabinoid, CB2 | 4 | 2011 | 27 | 0.460 |
Why?
|
| Mice | 21 | 2022 | 8472 | 0.460 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2013 | 45 | 0.450 |
Why?
|
| Polyunsaturated Alkamides | 2 | 2013 | 17 | 0.440 |
Why?
|
| Arachidonic Acids | 2 | 2013 | 97 | 0.440 |
Why?
|
| Cannabinoid Receptor Modulators | 3 | 2010 | 16 | 0.430 |
Why?
|
| Mice, Inbred C57BL | 13 | 2018 | 2790 | 0.430 |
Why?
|
| Allergens | 2 | 2013 | 54 | 0.410 |
Why?
|
| TRPV Cation Channels | 1 | 2011 | 17 | 0.400 |
Why?
|
| CD11b Antigen | 5 | 2015 | 47 | 0.390 |
Why?
|
| Receptors, Chemokine | 4 | 2015 | 26 | 0.360 |
Why?
|
| Animals | 24 | 2022 | 20877 | 0.350 |
Why?
|
| Dendritic Cells | 2 | 2008 | 201 | 0.340 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2022 | 285 | 0.330 |
Why?
|
| Papillomavirus Infections | 2 | 2022 | 163 | 0.330 |
Why?
|
| Fruit | 2 | 2013 | 86 | 0.320 |
Why?
|
| Lymphocyte Activation | 3 | 2011 | 397 | 0.320 |
Why?
|
| Nanoparticles | 2 | 2022 | 254 | 0.310 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 1293 | 0.310 |
Why?
|
| Haptens | 1 | 2006 | 11 | 0.300 |
Why?
|
| Mannose | 1 | 2006 | 9 | 0.300 |
Why?
|
| Serum Albumin, Bovine | 1 | 2006 | 43 | 0.290 |
Why?
|
| Mannitol | 1 | 2006 | 25 | 0.290 |
Why?
|
| Immunoglobulin G | 2 | 2022 | 481 | 0.280 |
Why?
|
| Cytokines | 7 | 2018 | 866 | 0.280 |
Why?
|
| Cells, Cultured | 5 | 2020 | 2673 | 0.260 |
Why?
|
| Oncogene Proteins, Viral | 2 | 2022 | 21 | 0.260 |
Why?
|
| Receptors, Cannabinoid | 5 | 2011 | 26 | 0.250 |
Why?
|
| Chemoradiotherapy | 2 | 2022 | 54 | 0.240 |
Why?
|
| Female | 20 | 2022 | 38015 | 0.240 |
Why?
|
| Mast Cells | 2 | 2015 | 113 | 0.240 |
Why?
|
| Mice, Knockout | 6 | 2018 | 1692 | 0.230 |
Why?
|
| Apoptosis | 6 | 2011 | 1640 | 0.220 |
Why?
|
| Enterotoxins | 2 | 2014 | 40 | 0.220 |
Why?
|
| Trichuriasis | 1 | 2022 | 2 | 0.210 |
Why?
|
| Mouth | 1 | 2002 | 64 | 0.210 |
Why?
|
| Bone Marrow Cells | 3 | 2013 | 217 | 0.210 |
Why?
|
| Skin Tests | 3 | 2013 | 30 | 0.210 |
Why?
|
| Tuberculosis | 1 | 2022 | 77 | 0.200 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2022 | 103 | 0.200 |
Why?
|
| Immunoglobulin E | 3 | 2013 | 91 | 0.200 |
Why?
|
| Endocannabinoids | 2 | 2013 | 32 | 0.200 |
Why?
|
| Cell Proliferation | 4 | 2015 | 1173 | 0.190 |
Why?
|
| Anti-Infective Agents | 1 | 2022 | 166 | 0.190 |
Why?
|
| Intestines | 1 | 2021 | 114 | 0.190 |
Why?
|
| Concanavalin A | 2 | 2011 | 22 | 0.180 |
Why?
|
| Arginase | 2 | 2018 | 15 | 0.170 |
Why?
|
| Stilbenes | 2 | 2011 | 57 | 0.170 |
Why?
|
| Th1 Cells | 2 | 2022 | 101 | 0.170 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 121 | 0.170 |
Why?
|
| Carbon | 1 | 2020 | 122 | 0.170 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2011 | 126 | 0.170 |
Why?
|
| Adaptive Immunity | 1 | 2018 | 37 | 0.170 |
Why?
|
| Receptors, Aryl Hydrocarbon | 3 | 2011 | 46 | 0.160 |
Why?
|
| Cerebral Hemorrhage | 1 | 2020 | 198 | 0.160 |
Why?
|
| Granulocytes | 1 | 2018 | 22 | 0.160 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2018 | 15 | 0.160 |
Why?
|
| Endometrium | 1 | 2018 | 31 | 0.160 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2018 | 21 | 0.160 |
Why?
|
| Carcinoma | 1 | 2020 | 215 | 0.160 |
Why?
|
| Endometriosis | 1 | 2018 | 56 | 0.160 |
Why?
|
| Immunity, Innate | 1 | 2018 | 156 | 0.160 |
Why?
|
| NF-kappa B | 3 | 2011 | 432 | 0.150 |
Why?
|
| Molecular Structure | 1 | 2018 | 397 | 0.150 |
Why?
|
| Mouth Neoplasms | 1 | 2019 | 206 | 0.150 |
Why?
|
| Protein Transport | 2 | 2008 | 280 | 0.140 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 467 | 0.140 |
Why?
|
| Chemokines | 3 | 2018 | 119 | 0.140 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 3 | 2021 | 91 | 0.130 |
Why?
|
| p-Methoxy-N-methylphenethylamine | 1 | 2015 | 4 | 0.130 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2015 | 26 | 0.130 |
Why?
|
| Chemokine CXCL1 | 1 | 2015 | 21 | 0.130 |
Why?
|
| Tumor Microenvironment | 3 | 2022 | 211 | 0.130 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2015 | 101 | 0.130 |
Why?
|
| Pregnancy | 2 | 2018 | 2331 | 0.130 |
Why?
|
| Transcriptional Activation | 1 | 2015 | 226 | 0.120 |
Why?
|
| Humans | 16 | 2022 | 68525 | 0.120 |
Why?
|
| Cross Reactions | 1 | 2013 | 57 | 0.120 |
Why?
|
| Cystitis | 1 | 2013 | 18 | 0.120 |
Why?
|
| Cystitis, Interstitial | 1 | 2013 | 12 | 0.120 |
Why?
|
| Liver | 2 | 2011 | 1118 | 0.120 |
Why?
|
| Chemokine CXCL10 | 1 | 2013 | 21 | 0.120 |
Why?
|
| Antigens, Differentiation | 1 | 2013 | 49 | 0.120 |
Why?
|
| Th17 Cells | 1 | 2014 | 116 | 0.120 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2013 | 272 | 0.120 |
Why?
|
| Piperidines | 2 | 2011 | 123 | 0.120 |
Why?
|
| Immunologic Factors | 1 | 2014 | 87 | 0.120 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2013 | 230 | 0.120 |
Why?
|
| Histones | 1 | 2014 | 111 | 0.120 |
Why?
|
| Chemokine CCL2 | 1 | 2013 | 101 | 0.120 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 2550 | 0.110 |
Why?
|
| Adjuvants, Immunologic | 2 | 2022 | 63 | 0.110 |
Why?
|
| Colitis | 1 | 2014 | 156 | 0.110 |
Why?
|
| Pyrazoles | 2 | 2011 | 190 | 0.110 |
Why?
|
| Antibodies | 1 | 2013 | 241 | 0.110 |
Why?
|
| Signal Transduction | 2 | 2019 | 2688 | 0.110 |
Why?
|
| HIV Antigens | 1 | 2011 | 9 | 0.100 |
Why?
|
| Interferon-gamma | 2 | 2013 | 241 | 0.100 |
Why?
|
| Antibodies, Blocking | 1 | 2010 | 17 | 0.100 |
Why?
|
| Anticarcinogenic Agents | 1 | 2011 | 52 | 0.100 |
Why?
|
| Sirtuin 1 | 1 | 2011 | 47 | 0.100 |
Why?
|
| Psychotropic Drugs | 1 | 2011 | 83 | 0.100 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2010 | 29 | 0.100 |
Why?
|
| Fetus | 1 | 2011 | 157 | 0.100 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2011 | 88 | 0.100 |
Why?
|
| Human papillomavirus 16 | 2 | 2022 | 19 | 0.100 |
Why?
|
| Mice, Inbred C3H | 1 | 2010 | 134 | 0.100 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 1172 | 0.100 |
Why?
|
| Lymphoma | 1 | 2011 | 116 | 0.100 |
Why?
|
| Cell Differentiation | 2 | 2020 | 1034 | 0.090 |
Why?
|
| Bone Marrow | 1 | 2010 | 168 | 0.090 |
Why?
|
| Marijuana Smoking | 1 | 2011 | 108 | 0.090 |
Why?
|
| Drug Discovery | 1 | 2011 | 94 | 0.090 |
Why?
|
| Repressor Proteins | 2 | 2022 | 182 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2014 | 447 | 0.090 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2011 | 131 | 0.090 |
Why?
|
| Graft vs Host Disease | 1 | 2011 | 163 | 0.080 |
Why?
|
| Organ Transplantation | 1 | 2010 | 110 | 0.080 |
Why?
|
| Mitochondria | 2 | 2020 | 643 | 0.080 |
Why?
|
| Membrane Microdomains | 1 | 2008 | 32 | 0.080 |
Why?
|
| Aspartate Aminotransferases | 1 | 2008 | 87 | 0.080 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2008 | 160 | 0.080 |
Why?
|
| Leukocytes | 1 | 2008 | 99 | 0.080 |
Why?
|
| Alanine Transaminase | 1 | 2008 | 137 | 0.080 |
Why?
|
| Heterozygote | 1 | 2008 | 174 | 0.080 |
Why?
|
| Cell Communication | 1 | 2008 | 116 | 0.080 |
Why?
|
| Interleukin-2 | 1 | 2008 | 133 | 0.080 |
Why?
|
| Amination | 1 | 2006 | 4 | 0.070 |
Why?
|
| Receptors, Estrogen | 1 | 2007 | 142 | 0.070 |
Why?
|
| Cannabinoid Receptor Antagonists | 3 | 2011 | 10 | 0.070 |
Why?
|
| Graft Rejection | 1 | 2010 | 458 | 0.070 |
Why?
|
| bcl-Associated Death Protein | 1 | 2006 | 19 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 756 | 0.070 |
Why?
|
| Leukemia, T-Cell | 1 | 2006 | 21 | 0.070 |
Why?
|
| Reactive Oxygen Species | 2 | 2020 | 499 | 0.070 |
Why?
|
| Time Factors | 2 | 2021 | 4655 | 0.070 |
Why?
|
| Hepatocytes | 1 | 2008 | 205 | 0.070 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2007 | 133 | 0.070 |
Why?
|
| Tissue Distribution | 2 | 2022 | 282 | 0.070 |
Why?
|
| Rabbits | 1 | 2006 | 509 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2022 | 626 | 0.070 |
Why?
|
| Cattle | 1 | 2006 | 475 | 0.070 |
Why?
|
| Polychlorinated Dibenzodioxins | 1 | 2005 | 38 | 0.070 |
Why?
|
| MAP Kinase Signaling System | 1 | 2006 | 247 | 0.070 |
Why?
|
| Oxidation-Reduction | 1 | 2006 | 567 | 0.060 |
Why?
|
| Lactones | 1 | 2004 | 64 | 0.060 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2004 | 140 | 0.060 |
Why?
|
| Antigen Presentation | 1 | 2004 | 76 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 1745 | 0.060 |
Why?
|
| Defensins | 1 | 2022 | 3 | 0.060 |
Why?
|
| Macrophage-1 Antigen | 1 | 2022 | 10 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2021 | 7028 | 0.060 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 370 | 0.050 |
Why?
|
| Trichuris | 1 | 2022 | 2 | 0.050 |
Why?
|
| Mice, Inbred AKR | 1 | 2022 | 8 | 0.050 |
Why?
|
| Vaccines, Synthetic | 1 | 2022 | 19 | 0.050 |
Why?
|
| Papillomavirus E7 Proteins | 1 | 2022 | 13 | 0.050 |
Why?
|
| Immunity, Mucosal | 1 | 2022 | 19 | 0.050 |
Why?
|
| Immunoblotting | 1 | 2002 | 254 | 0.050 |
Why?
|
| Syndrome | 1 | 2002 | 255 | 0.050 |
Why?
|
| Interleukin-12 | 1 | 2022 | 75 | 0.050 |
Why?
|
| Mucous Membrane | 1 | 2022 | 66 | 0.050 |
Why?
|
| Administration, Intranasal | 1 | 2022 | 88 | 0.050 |
Why?
|
| Antibody Formation | 1 | 2022 | 93 | 0.050 |
Why?
|
| Liposomes | 1 | 2022 | 107 | 0.050 |
Why?
|
| Immunity, Cellular | 1 | 2022 | 80 | 0.050 |
Why?
|
| Immunoglobulin A | 1 | 2022 | 79 | 0.050 |
Why?
|
| Immunization | 1 | 2022 | 86 | 0.050 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2021 | 27 | 0.050 |
Why?
|
| Ki-67 Antigen | 1 | 2021 | 28 | 0.050 |
Why?
|
| Lectins, C-Type | 1 | 2021 | 39 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 1849 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2022 | 532 | 0.050 |
Why?
|
| Vaccination | 1 | 2022 | 182 | 0.050 |
Why?
|
| DNA Breaks, Single-Stranded | 1 | 2020 | 1 | 0.050 |
Why?
|
| Hemin | 1 | 2020 | 10 | 0.050 |
Why?
|
| Male | 5 | 2019 | 37281 | 0.050 |
Why?
|
| Nitric Oxide | 1 | 2022 | 382 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2021 | 230 | 0.050 |
Why?
|
| Deferoxamine | 1 | 2020 | 45 | 0.050 |
Why?
|
| Palatine Tonsil | 1 | 2019 | 8 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 265 | 0.040 |
Why?
|
| CTLA-4 Antigen | 1 | 2019 | 45 | 0.040 |
Why?
|
| Interferons | 1 | 2019 | 36 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2019 | 111 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2021 | 226 | 0.040 |
Why?
|
| Cellular Senescence | 1 | 2020 | 112 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2020 | 149 | 0.040 |
Why?
|
| DNA Damage | 1 | 2020 | 190 | 0.040 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2019 | 86 | 0.040 |
Why?
|
| Caspases | 2 | 2011 | 194 | 0.040 |
Why?
|
| Thymus Gland | 2 | 2011 | 97 | 0.040 |
Why?
|
| Fas Ligand Protein | 2 | 2011 | 64 | 0.040 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2018 | 9 | 0.040 |
Why?
|
| Mice, Inbred DBA | 2 | 2011 | 120 | 0.040 |
Why?
|
| Iron | 1 | 2020 | 197 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 2013 | 1446 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2019 | 431 | 0.040 |
Why?
|
| Adult | 3 | 2021 | 21375 | 0.040 |
Why?
|
| Prognosis | 1 | 2022 | 2093 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2019 | 617 | 0.030 |
Why?
|
| CD11c Antigen | 1 | 2014 | 18 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 2014 | 53 | 0.030 |
Why?
|
| Lung | 1 | 2020 | 849 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2014 | 110 | 0.030 |
Why?
|
| Dextran Sulfate | 1 | 2014 | 88 | 0.030 |
Why?
|
| Methylation | 1 | 2014 | 56 | 0.030 |
Why?
|
| Chemokine CXCL11 | 1 | 2013 | 3 | 0.030 |
Why?
|
| Chemokine CXCL9 | 1 | 2013 | 8 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2014 | 144 | 0.030 |
Why?
|
| Models, Biological | 2 | 2009 | 981 | 0.030 |
Why?
|
| Genomics | 1 | 2014 | 167 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 3702 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2013 | 357 | 0.030 |
Why?
|
| Biological Evolution | 1 | 2013 | 86 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 208 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2014 | 258 | 0.030 |
Why?
|
| Phylogeny | 1 | 2013 | 196 | 0.030 |
Why?
|
| Transcriptome | 1 | 2014 | 164 | 0.030 |
Why?
|
| Body Weight | 1 | 2014 | 554 | 0.030 |
Why?
|
| Thymocytes | 1 | 2011 | 11 | 0.030 |
Why?
|
| Chromium Radioisotopes | 1 | 2011 | 11 | 0.030 |
Why?
|
| Lymphopoiesis | 1 | 2011 | 16 | 0.030 |
Why?
|
| Cannabinoid Receptor Agonists | 1 | 2011 | 20 | 0.030 |
Why?
|
| Splenomegaly | 1 | 2011 | 13 | 0.030 |
Why?
|
| HIV Antibodies | 1 | 2011 | 28 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 1082 | 0.030 |
Why?
|
| fas Receptor | 1 | 2011 | 54 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2011 | 108 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2011 | 94 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2011 | 138 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2011 | 242 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2011 | 238 | 0.020 |
Why?
|
| Indoles | 1 | 2011 | 146 | 0.020 |
Why?
|
| Spleen | 1 | 2011 | 301 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2011 | 489 | 0.020 |
Why?
|
| HIV-1 | 1 | 2011 | 177 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2010 | 99 | 0.020 |
Why?
|
| Middle Aged | 2 | 2021 | 21119 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 1851 | 0.020 |
Why?
|
| Weight Loss | 1 | 2011 | 319 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2011 | 510 | 0.020 |
Why?
|
| Autoimmune Diseases | 1 | 2009 | 186 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2006 | 20 | 0.020 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2006 | 22 | 0.020 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2006 | 17 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2006 | 59 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2006 | 85 | 0.020 |
Why?
|
| Pertussis Toxin | 1 | 2006 | 72 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2006 | 138 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2006 | 122 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 175 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2005 | 55 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2005 | 147 | 0.020 |
Why?
|
| Aged | 1 | 2021 | 14842 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2005 | 113 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2006 | 852 | 0.020 |
Why?
|
| Bryostatins | 1 | 2004 | 32 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2006 | 447 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2004 | 33 | 0.020 |
Why?
|
| Macrolides | 1 | 2004 | 48 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2004 | 82 | 0.020 |
Why?
|
| Fetal Blood | 1 | 2004 | 131 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2004 | 124 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 1015 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 250 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2004 | 270 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2004 | 308 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2005 | 614 | 0.010 |
Why?
|
| DNA | 1 | 2005 | 597 | 0.010 |
Why?
|
| Phenotype | 1 | 2005 | 946 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 5708 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2005 | 1663 | 0.010 |
Why?
|
| Adolescent | 1 | 2013 | 8903 | 0.010 |
Why?
|